{
  "pmid": "16831981",
  "uid": "16831981",
  "title": "Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.",
  "abstract": "BACKGROUND: Individual markers of inflammation may add incremental predictive value in the context of conventionally available risk factors. We evaluated the ability of 9 inflammatory biomarkers, microalbuminuria, and N-terminal pro-brain natriuretic peptide (Nt-proBNP) to improve cardiovascular risk prediction beyond that obtained from traditional risk factors in a secondary-prevention population. METHODS AND RESULTS: We measured biomarkers representing the acute-phase reaction (C-reactive protein, fibrinogen, and interleukin-6), proinflammatory pathways (soluble tumor necrosis factor receptor-1 and -2, soluble interleukin-1 receptor antagonist, and interleukin-18), endothelial activation (soluble vascular adhesion molecule-1 and soluble intercellular adhesion molecule-1), Nt-proBNP, and microalbuminuria in 3199 study individuals of the Heart Outcomes Prevention Evaluation (HOPE) Study and assessed their association with risk of myocardial infarction, stroke, or cardiovascular death (primary outcome, n=501) over 4.5 years of follow-up. In a backward Cox regression procedure that included risk factors and biomarkers, Nt-proBNP (hazard ratio [HR] 1.72 per increment SD, 95% CI 1.39 to 2.12; P<0.0001), soluble intercellular adhesion molecule-1 (HR 1.46, 95% CI 1.19 to 1.80; P=0.0003), microalbuminuria (HR 1.55, 95% CI 1.22 to 1.98; P=0.0004), soluble interleukin-1 receptor antagonist (HR 1.30, 95% CI 1.05 to 1.61; P=0.02), and fibrinogen (HR 1.31, 95% CI 1.05 to 1.62; P=0.02) remained significantly related to the primary outcome. Only inclusion of Nt-proBNP provided incremental information above that obtained by models of traditional risk factors. CONCLUSIONS: Although levels of various inflammatory biomarkers are significantly related to future cardiovascular risk, their incremental predictive value is modest. A model consisting of simple traditional risk factors and Nt-proBNP provided the best clinical prediction in the secondary-prevention population.",
  "authors": [
    {
      "last_name": "Blankenberg",
      "fore_name": "Stefan",
      "initials": "S",
      "name": "Stefan Blankenberg",
      "affiliations": [
        "Department of Medicine II, Johannes Gutenberg-University Mainz, Mainz, Germany."
      ]
    },
    {
      "last_name": "McQueen",
      "fore_name": "Matthew J",
      "initials": "MJ",
      "name": "Matthew J McQueen",
      "affiliations": []
    },
    {
      "last_name": "Smieja",
      "fore_name": "Marek",
      "initials": "M",
      "name": "Marek Smieja",
      "affiliations": []
    },
    {
      "last_name": "Pogue",
      "fore_name": "Janice",
      "initials": "J",
      "name": "Janice Pogue",
      "affiliations": []
    },
    {
      "last_name": "Balion",
      "fore_name": "Cynthia",
      "initials": "C",
      "name": "Cynthia Balion",
      "affiliations": []
    },
    {
      "last_name": "Lonn",
      "fore_name": "Eva",
      "initials": "E",
      "name": "Eva Lonn",
      "affiliations": []
    },
    {
      "last_name": "Rupprecht",
      "fore_name": "Hans J",
      "initials": "HJ",
      "name": "Hans J Rupprecht",
      "affiliations": []
    },
    {
      "last_name": "Bickel",
      "fore_name": "Christoph",
      "initials": "C",
      "name": "Christoph Bickel",
      "affiliations": []
    },
    {
      "last_name": "Tiret",
      "fore_name": "Laurence",
      "initials": "L",
      "name": "Laurence Tiret",
      "affiliations": []
    },
    {
      "last_name": "Cambien",
      "fore_name": "Francois",
      "initials": "F",
      "name": "Francois Cambien",
      "affiliations": []
    },
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel",
      "initials": "H",
      "name": "Hertzel Gerstein",
      "affiliations": []
    },
    {
      "last_name": "Münzel",
      "fore_name": "Thomas",
      "initials": "T",
      "name": "Thomas Münzel",
      "affiliations": []
    },
    {
      "last_name": "Yusuf",
      "fore_name": "Salim",
      "initials": "S",
      "name": "Salim Yusuf",
      "affiliations": []
    },
    {
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Circulation",
    "iso_abbreviation": "Circulation",
    "issn": "1524-4539",
    "issn_type": "Electronic",
    "volume": "114",
    "issue": "3",
    "pub_year": "2006",
    "pub_month": "Jul",
    "pub_day": "18"
  },
  "start_page": "201",
  "end_page": "208",
  "pages": "201-8",
  "language": "eng",
  "publication_types": [
    "Comparative Study",
    "Journal Article",
    "Multicenter Study",
    "Randomized Controlled Trial",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Aged",
    "Angiotensin-Converting Enzyme Inhibitors",
    "Biomarkers",
    "C-Reactive Protein",
    "Coronary Artery Disease",
    "Female",
    "Fibrinogen",
    "Heart Diseases",
    "Humans",
    "Interleukin-6",
    "Male",
    "Middle Aged",
    "Myocardial Infarction",
    "Natriuretic Peptide, Brain",
    "Predictive Value of Tests",
    "Ramipril",
    "Risk Factors",
    "Vitamin E"
  ],
  "article_ids": {
    "pubmed": "16831981",
    "doi": "10.1161/CIRCULATIONAHA.105.590927",
    "pii": "CIRCULATIONAHA.105.590927"
  },
  "doi": "10.1161/CIRCULATIONAHA.105.590927",
  "dates": {
    "completed": "2006-08-14",
    "revised": "2022-04-08"
  },
  "chemicals": [
    "Angiotensin-Converting Enzyme Inhibitors",
    "Biomarkers",
    "Interleukin-6",
    "Natriuretic Peptide, Brain",
    "Vitamin E",
    "Fibrinogen",
    "C-Reactive Protein",
    "Ramipril"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:11:41.224370",
    "pmid": "16831981"
  }
}